Ticker Details
Janux Therapeutics, Inc.
IPO Date:	June 11, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$883.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.81 | 3.52%
Avg Daily Range (30 D):	$0.25 | 1.82%
Avg Daily Range (90 D):	$0.30 | 2.06%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.79M
Avg Daily Volume (90 D):	1.45M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	77

Institutional Trades
Total Institutional Trades:	1,687
Avg Institutional Trade:	$2.22M
Avg Institutional Trade (30 D):	$3.35M
Avg Institutional Trade (90 D):	$2.45M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.35M
Avg Closing Trade (30 D):	$3.03M
Avg Closing Trade (90 D):	$3.27M
Avg Closing Volume:	117.62K

News

Jan 22, 2026 @ 7:02 PM Janux Therapeutics Strikes Bristol Myers Biotech D... Source: Vandana Singh

Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman

May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.83	$-.51	$-1.83
Diluted EPS	$-1.83	$-.51	$-1.83
Revenue	$10M	$M	$10M
Gross Profit
Net Income / Loss	$-113.63M	$-31.95M	$-113.63M
Operating Income / Loss	$-157.67M	$-42.4M	$-157.67M
Cost of Revenue
Net Cash Flow	$-378.27M	$3.95M	$-378.27M
PE Ratio